1-3 of 3
Lynne M. Howells
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability

Glen R.B. Irving, Lynne M. Howells, Stewart Sale, Ines Kralj-Hans, Wendy S. Atkin, Susan K. Clark, Robert G. Britton, Donald J.L. Jones, Edwina N. Scott, David P. Berry, David Hemingway, Andrew S. Miller, Karen Brown, Andreas J. Gescher, William P. Steward
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2013) 6 (2): 119–128.
https://doi.org/10.1158/1940-6207.CAPR-12-0281
Published: 03 February 2013
View articletitled, Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability
Open the PDF for Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability in another window
Journal Articles

Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics

Lynne M. Howells, D.P. Berry, P.J. Elliott, E.W. Jacobson, E. Hoffmann, B. Hegarty, K. Brown, W.P. Steward, A.J. Gescher
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (9): 1419–1425.
https://doi.org/10.1158/1940-6207.CAPR-11-0148
Published: 04 September 2011
View articletitled, Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics
Open the PDF for Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics in another window
Journal Articles

Preclinical Colorectal Cancer Chemopreventive Efficacy and p53-Modulating Activity of 3′,4′,5′-Trimethoxyflavonol, a Quercetin Analogue

Lynne M. Howells, Robert G. Britton, Marco Mazzoletti, Peter Greaves, Massimo Broggini, Karen Brown, William P. Steward, Andreas J. Gescher, Stewart Sale
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (8): 929–939.
https://doi.org/10.1158/1940-6207.CAPR-09-0236
Published: 04 August 2010
View articletitled, Preclinical Colorectal Cancer Chemopreventive Efficacy and p53-Modulating Activity of 3′,4′,5′-Trimethoxyflavonol, a Quercetin Analogue
Open the PDF for Preclinical Colorectal Cancer Chemopreventive Efficacy and p53-Modulating Activity of 3′,4′,5′-Trimethoxyflavonol, a Quercetin Analogue in another window